2026-07-06T13:10:42-04:00 2025-12-31 990PF 2025-01-01 522143781 ROSE SALTER MEDICAL RESEARCH FOUNDATION LTD ROSE 9498134026 34 VERSAILLES NEWPORT COAST CA 926571065 Marc Rendell Medical Director 9498134026 2026-07-07 2025 2025-03-06 01:10:19Z X 884315 X 0 X 2461 2461 2461 18738 18738 18738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21199 21199 21199 22000 22000 22000 22000 1504 1504 1504 1504 791 791 791 791 0 0 0 0 1843 1843 1843 1843 0 0 0 0 0 0 0 0 3972 3972 3972 3972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 30110 30110 30110 30110 0 0 30110 30110 30110 30110 -8911 0 0 0 0 0 86056 45259 45259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 75000 75000 700016 764056 764056 0 0 0 0 0 0 0 0 786072 884315 884315 0 0 0 0 0 0 0 0 0 0 0 0 0 X 786072 884315 0 0 786072 884315 786072 884315 786072 -8911 107154 884315 884315 0 0 0 0 0 0 0 false false false 0 0 0 false false false false true true CA true true false false false true rsmrf. org Marc Rendell MD 9498134026 34 VERSAILLES NEWPORT COAST CA 926571065 false false false false false false false false false false false false false false false false false false false false false Binh Ngo 34 Versailles Newport Coast CA 92657 President 4.00 0 0 0 Marc Rendell 34 Versailles Newport Coast CA 92657 Medical Director 20.00 22000 0 0 NONE NONE Epidemiology of melanoma mortality We are studying the Optum database to determine correlates of melanoma mortality and health behavior. We are preparing a manuscript 0 We have published several commentaries on research questions in the past year: NGO B. A SMALL STUDY OF GREAT PROMISE IN WENADI M ET AL. HUMAN PAPILLOMAVIRUS VACCINATION AND ACTINIC KERATOSIS BURDEN THE VAXAK RANDOMIZED CLINICAL TRIAL JUNE 20 2025. JAMA DERMATOL PUBLISHED ONLINE: MARCH 6 20252025;161;6:605-614. DOI:10.1001 JAMADERMATOL.2025.0531 3.NGO B OF BENEFIT AND RISK. US FDA SAFETY LABELING CHANGE FOR MRNA COVID-19 VACCINES IN PRASAD V AND MAKARY M. JAMA NETWORK VIEWPOINT PUBLISHED ONLINE JULY 14 2025 DOI: 10.1001 JAMA.2025.12675 4.NGO B EXCISION MARGINS FOR MELANOMA IN SITU: CAN A VALID STUDY BE DESIGNED? SEPTEMBER 4 2025 IN DESSINIOTI C ET AL LOCAL RECURRENCE AND SURVIVAL IN PATIENTS WITH MELANOMA IN SITUDOI: 10.1001 JAMADERMATOL.2025.3078 5.NGO B LET US SEE A LARGER STUDY OF AZELASTINE TO PREVENT UPPER RESPIRATORY INFECTION OCTOBER 14 2025 IN LEHR T ET AL AZELASTINE NASAL SPRAY FOR PREVENTION OF SARS-COV-2 INFECTIONS A PHASE 2 RANDOMIZED CLINICAL TRIAL JAMA INTERN MED 0 Marc Rendell M.D. was co-editor of the book Controversies in the Pandemic is a 782-page medical reference book published by Jaypee Brothers Medical Publishers. Edited by Dr. Joseph Varon Dr. Paul E. Marik Dr. Marc Rendell and other clinical experts the textbook critically examines the polarizing debates shifting guidelines and therapeutic disagreements that emerged during the COVID-19 crisis. 0 Dr. Rendell published several comments on issues in the medical literature:Rendell M GLP-1Receptor Agonists and the Brain COMMENT ON Hendershot CS Bremmer MP Paladino MB et al. Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. Published online February 12 2025. Rendell M Indirect Cost Rates Separate but Not Equal COMMENT ON Walensky RP Walensky LD. US Science in Peril. JAMA. Published online February 14 2025. 0 none 0 732036 65658 0 797694 0 0 797694 11965 785729 39286 X 30110 0 0 0 0 30110 1999-12-09 X 0 0 0 0 0 0 0 0 0 0 30110 27569 24000 31149 112828 0 0 0 0 0 30110 27569 24000 31149 112828 0 0 25984 0 25984 0 0 0 0 0 26191 22665 26247 0 75103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 None None X 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 false false false false false false false false false false carruth compliance 750 750 750 750 payroll accounting 1093 1093 1093 1093 cetera invetments brokerage account 396974 396974 Wells Fargo Stock Portfolio 367082 367082 0 75000 75000 75000 increase in value of investments 107154 social security CA local EDD 3972 3972 3972 3972